Mir-509-3p targets SLC25A13 to regulate ferroptosis and protect retinal endothelial cells in diabetic retinopathy
Acta Diabetologica · 2024
DOI: 10.1007/s00592-024-02400-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Diabetologica, 2024. Verfasst von Meiqing Ren und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, School of medicine, Zhongda Hospital, Southeast University, Nanjing, 210009, China. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Ferroptosis, MicroRNAs, Endothelial Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, School of medicine, Zhongda Hospital, Southeast University, Nanjing, 210009, China.
- The Diabetes Research Institute, Southeast University, Nanjing, 210009, China. jxpinggu@163.com.
Zitieren
APA
Ren, M., Xu, Q., Luan, J., Ni, Y., & Xie, B. (2024). Mir-509-3p targets SLC25A13 to regulate ferroptosis and protect retinal endothelial cells in diabetic retinopathy. Acta Diabetologica. https://doi.org/10.1007/s00592-024-02400-3
Vancouver
Ren M, Xu Q, Luan J, Ni Y, Xie B. Mir-509-3p targets SLC25A13 to regulate ferroptosis and protect retinal endothelial cells in diabetic retinopathy. Acta Diabetologica. 2024. doi:10.1007/s00592-024-02400-3
BibTeX
@article{Ren2024,
author = {Ren, Meiqing and Xu, Qian and Luan, Jie and Ni, Yan and Xie, Bo},
title = {Mir-509-3p targets SLC25A13 to regulate ferroptosis and protect retinal endothelial cells in diabetic retinopathy},
journal = {Acta Diabetologica},
year = {2024},
doi = {10.1007/s00592-024-02400-3}
}
EUVIMED